本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

IO Biotech, Inc.

1.40
-0.0995-6.63%
成交量:25.70万
成交额:34.95万
市值:9,226.62万
市盈率:-0.94
高:1.50
开:1.50
低:1.20
收:1.50
数据加载中...
2022/04/14

重要事件披露

8-K - Current report
2022/03/31

重要事件披露

8-K - Current report
2022/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

重要事件披露

8-K - Current report
2022/03/03

重要事件披露

8-K - Current report
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/08

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/12/17

重要事件披露

8-K - Current report
2021/12/17

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/12/06

重要事件披露

8-K - Current report
2021/11/19

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/05

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/01

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/26

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933